|
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.
|
Apr 2013
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Thrombosis in paroxysmal nocturnal hemoglobinuria.
|
Apr 2013
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Validation of the revised international prognostic scoring system in treated patients with myelodysplastic syndromes.
|
Apr 2013
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.
|
Apr 2013
|
Pediatr Transplant
|
aplastic anemia
|
|
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.
|
Apr 2013
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
How we treat lower risk myelodysplastic syndromes.
|
Apr 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
|
Apr 2013
|
Pediatr Transplant
|
aplastic anemia
|
|
Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Prognostication in Myelodysplastic Syndromes: Beyond the International Prognostic Scoring System (IPSS)
|
Apr 2013
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
